Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 200,453 | 193,015 | 164,036 | 127,950 | 92,839 |
| Cost of Goods | 89,347 | 83,589 | 63,062 | 48,806 | 41,129 |
| Gross Profit | 111,106 | 109,426 | 100,974 | 79,144 | 51,710 |
| Operating Expenses | 131,976 | 137,860 | 102,840 | 70,793 | 38,180 |
| Operating Income | -20,523 | -27,845 | -1,804 | 9,157 | 13,659 |
| Interest Expense | -5,239 | 2,071 | 2,573 | 1,741 | 333 |
| Other Income | 9,584 | 14,207 | 5,637 | -1,478 | 1,104 |
| Pre-tax Income | -5,700 | -15,709 | 1,260 | 5,938 | 14,430 |
| Income Tax | 320 | -3,561 | -1,224 | 2,911 | -4,981 |
| Net Income Continuous | -6,020 | -12,148 | 2,484 | 3,027 | 19,411 |
| Minority Interests | N/A | N/A | -92 | 26 | N/A |
| Net Income | $-6,020 | $-12,148 | $2,576 | $3,001 | $19,411 |
| EPS Basic Total Ops | -0.05 | -0.09 | 0.02 | 0.00 | 0.11 |
| EPS Basic Continuous Ops | -0.05 | -0.09 | 0.02 | 0.04 | 0.67 |
| EPS Diluted Total Ops | -0.05 | -0.09 | 0.02 | 0.00 | 0.10 |
| EPS Diluted Continuous Ops | -0.05 | -0.09 | 0.02 | 0.04 | 0.60 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.04 | 0.03 | 0.09 | N/A |
| EBITDA(a) | $-10,033 | $-18,615 | $3,855 | $10,399 | $14,262 |